Related Experiment Video
Updated: Jun 12, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein
Congwen Wei1, Caifei Ni, Ting Song
1Beijing Institute of Biotechnology, China.
Abstract:
Previous studies have shown that both hepatitis A virus and hepatitis C virus inhibit innate immunity by cleaving the mitochondrial antiviral signaling (MAVS) protein, an essential component of the virus-activated signaling pathway that activates NF-kappaB and IFN regulatory factor-3 to induce the production of type I IFN. For human hepatitis B virus (HBV), hepatitis B s-Ag, hepatitis B e-Ag, or HBV virions have been shown to suppress TLR-induced antiviral activity with reduced IFN-beta production and subsequent induction of IFN-stimulated genes. However, HBV-mediated suppression of the RIG-I-MDA5 pathway is unknown. In this study, we found that HBV suppressed poly(deoxyadenylate-thymidylate)-activated IFN-beta production in hepatocytes. Specifically, hepatitis B virus X (HBX) interacted with MAVS and promoted the degradation of MAVS through Lys(136) ubiquitin in MAVS protein, thus preventing the induction of IFN-beta. Further analysis of clinical samples revealed that MAVS protein was downregulated in hepatocellular carcinomas of HBV origin, which correlated with increased sensitivities of primary murine hepatocytes isolated from HBX knock-in transgenic mice upon vesicular stomatitis virus infections. By establishing a link between MAVS and HBX, this study suggests that HBV can target the RIG-I signaling by HBX-mediated MAVS downregulation, thereby attenuating the antiviral response of the innate immune system.
Insights
Hepatitis B virus (HBV) suppresses innate immunity by degrading the MAVS protein, a key part of the antiviral signaling pathway. This HBX-mediated mechanism weakens the immune response against HBV infection.
Area of Science:
- Virology
- Immunology
- Hepatology
Background:
- Hepatitis A and C viruses cleave MAVS, inhibiting innate immunity.
- Hepatitis B virus (HBV) components suppress TLR-induced antiviral activity, but its effect on the RIG-I-MDA5 pathway is unclear.
Purpose of the Study:
- To investigate HBV's impact on the RIG-I-MDA5 signaling pathway.
- To elucidate the mechanism of HBV-mediated innate immune suppression.
Main Methods:
- Hepatocytes were stimulated with poly(deoxyadenylate-thymidylate) to assess IFN-beta production.
- Interaction and degradation of MAVS protein by hepatitis B virus X (HBX) were analyzed.
- MAVS protein levels were examined in HBV-related hepatocellular carcinoma samples.
- Primary murine hepatocytes from HBX knock-in mice were infected with vesicular stomatitis virus.
Main Results:
- HBV suppressed poly(deoxyadenylate-thymidylate)-activated IFN-beta production in hepatocytes.
- HBX interacted with MAVS, promoting its degradation via Lys(136) ubiquitination, which blocked IFN-beta induction.
- MAVS protein was downregulated in HBV-origin hepatocellular carcinomas.
- Hepatocytes from HBX knock-in mice showed increased susceptibility to vesicular stomatitis virus.
Conclusions:
- HBV targets the RIG-I signaling pathway through HBX-mediated MAVS downregulation.
- This mechanism attenuates the innate immune system's antiviral response to HBV.
- MAVS downregulation is implicated in HBV pathogenesis and hepatocellular carcinoma development.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Inhibitors of Virion Maturation and Assembly
Viruses with RNA Genomes
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viral Hepatitis I: Introduction

